Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke

  • Craig S. Anderson, Thompson Robinson, Richard I. Lindley, Hisatomi Arima, Pablo M. Lavados, Tsong-Hai Lee, Joseph P. Broderick, Xiaoying Chen, Guofang Chen, Vijay K. Sharma, Jong S. Kim, Nguyen H. Thang, Yongjun Cao, Mark W. Parsons, Christopher Levi, Yining Huang, Verónica V. Olavarría, Andrew M. Demchuk, Philip M. Bath, Geoffrey A. Donnan, Sheila Martins, Octavio M. Pontes-Neto, Federico Silva, Stefano Ricci, Christine Roffe, Jeyaraj Pandian, Laurent Billot, Mark Woodward, Qiang Li, Xia Wang, Jiguang Wang, John Chalmers
  • New England Journal of Medicine, June 2016, New England Journal of Medicine (NEJM/MMS)
  • DOI: 10.1056/nejmoa1515510

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1056/nejmoa1515510

The following have contributed to this page: Prof Christine C Roffe